As of April 30, 2025, Evoke Pharma (EVOK) has a market cap of $4.016 million USD. According to our data, Evoke Pharma is ranked No.9069 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 30, 2025 | $4.02 M |
-38.86%
|
Dec 31, 2024 | $6.57 M |
-64.92%
|
Dec 29, 2023 | $18.72 M |
-60.82%
|
Dec 30, 2022 | $47.79 M |
-59.39%
|
Dec 31, 2021 | $0.12 B |
-78.68%
|
Dec 31, 2020 | $0.55 B |
59.26%
|
Dec 31, 2019 | $0.35 B |
-34.68%
|
Dec 31, 2018 | $0.53 B |
9.73%
|
Dec 29, 2017 | $0.48 B |
11.88%
|
Dec 30, 2016 | $0.43 B |
-38.79%
|
Dec 31, 2015 | $0.71 B |
-44.07%
|
Dec 31, 2014 | $1.26 B |
-20.81%
|
Dec 31, 2013 | $1.59 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Ironwood Pharmaceuticals
IRWD
|
$0.15 B |
0.000 M
|
![]() USA
|
![]() Pacira Biosciences
PCRX
|
$1.25 B |
0.000 M
|
![]() USA
|
![]() Collegium Pharmaceutical
COLL
|
$0.89 B |
0.000 M
|
![]() USA
|
![]() Assertio Therapeutics
ASRT
|
$63.15 M |
0.000 M
|
![]() USA
|
![]() Cara Therapeutics
CARA
|
$24.33 M |
0.000 M
|
![]() USA
|
![]() Nektar Therapeutics
NKTR
|
$0.14 B |
-0.000 M
|
![]() USA
|
![]() Trevena
TRVN
|
$1.05 M |
0.000 M
|
![]() USA
|
![]() Supernus Pharmaceuticals
SUPN
|
$1.81 B |
0.000 M
|
![]() USA
|
![]() Aquestive Therapeutics
AQST
|
$0.28 B |
-0.000 M
|
![]() USA
|
Market Cap | = | EVOK Stock Price | * | EVOK Shares Outstanding |
= | $2.69 | * | 1.49 M | |
= | $4.02 M |